Building Investor Confidence in Microbiome Drug Development; how to Promote And Restore Confidence

Time: 8:55 am
day: Day Two


• Numerous challenges from bench to bedside but overall industry progress
• Selecting therapeutically-relevant indications beyond C. difficile
• The impact of recent clinical setbacks – Lessons learned on how and when to enter clinic with microbiome therapeutics